Connect to share and comment

No Keystone XL pipeline this year, following new delay

WASHINGTON - The Canadian government demanded an answer immediately on the long-delayed Keystone XL pipeline. It has now received a reply from the United States government that amounts to: Maybe next year. The project is now paralyzed for an indefinite period, with the U.S. administration Friday announcing another delay in a process already beset by political and legal challenges. The announcement made it clear that Canadian pipeline backers will not get the answer they wanted in time for the summer construction season, pushing completion of the project until 2015 — at best.

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday. The agreement, which also included Dragoneer Investment Group, mutual fund T. Rowe Price Group and Sequoia Capital among its investors, valued the startup at $10 billion, according to The Wall Street Journal. That figure would make the website, that lets individuals rent out their homes to travelers, one of the most valuable websites in the world, ahead of publicly-traded hotel chains Wyndham Worldwide and Hyatt Hotels Corporation.

U.S. puts off decision on Keystone XL pipeline

Washington, Apr 18 (EFE).- The U.S. State Department said Friday that it will allow more time for eight federal agencies to weigh-in on the proposed Keystone XL pipeline. "Agencies need additional time based on the uncertainty created by the on-going litigation in the Nebraska Supreme Court which could ultimately affect the pipeline route in that state," the department said in a note.

US delays review of Keystone XL pipeline, likely punting decision until after Election Day

WASHINGTON - The Obama administration is extending indefinitely its review of the Keystone XL pipeline, the State Department said Friday, likely punting the decision over the controversial oil pipeline past the midterm elections.

US delays review of Keystone XL pipeline, likely punting decision until after Election Day

WASHINGTON - The Obama administration is extending indefinitely its review of the Keystone XL pipeline, the State Department said Friday, likely punting the decision over the controversial oil pipeline past the midterm elections.

US delays decision on Keystone pipeline project

The United States on Friday indefinitely extended the review process for a controversial Canada-to-US oil pipeline, potentially delaying a final decision on the project until beyond mid-term elections in November. The US State Department said eight federal agencies -- who had been given until the end of May to submit views on the matter -- would now have a longer window to weigh in on the long-delayed Keystone XL pipeline.

Supreme Court denies Teva stay in Copaxone patent fight

By Lawrence Hurley WASHINGTON (Reuters) - U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug. The decision could help pave the way for generic competitors of Teva's Copaxone drug to go on the market as soon as next month.

Supreme Court declines to block ruling on multiple sclerosis drug in patent dispute

WASHINGTON - Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world's bestselling multiple sclerosis drug to competition from generic rivals next month. The decision is a victory for rivals challenging the patents of Israel-based Teva Pharmaceutical Industries Ltd., maker of the drug Copaxone.

Supreme Court declines to block ruling on multiple sclerosis drug in patent dispute

WASHINGTON - The Supreme Court has declined to temporarily block a lower court ruling that opens the world's bestselling multiple sclerosis drug to competition from generic rivals. The order Friday from Chief Justice John Roberts is a victory for rivals challenging the maker of the drug Copaxone, Teva Pharmaceutical Industries Ltd.

AbbVie urges U.S. court to avoid gay rights issue in HIV drug case

By Nate Raymond (Reuters) - An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutional protections for gays and lesbians. In a brief filed with the 9th U.S. Circuit Court of Appeals in San Francisco on Thursday, AbbVie Inc said the full court should review an initial three-judge decision that found a gay man was improperly excluded from jury service due to his sexual orientation.
Syndicate content